Munakata T, Tanaka K, Mito M
Second Department of Surgery, Medical College, Asahikawa, Japan.
Nihon Geka Gakkai Zasshi. 1990 Jan;91(1):77-85.
Changes in phosphorus metabolites and intracellular pH in acute liver failure induced by D-galactosamine (GAL) were evaluated non-destructively and continuously using 31P-NMR spectroscopy. Furthermore, changes in these parameters under ischemia were also examined. GAL(1.0g/kg) was injected intravenously to male Wistar rats. NMR measurements in perfused livers were performed with a GX-270FT NMR spectrometer (JEOL). Typical changes in 31P-NMR spectra were observed after GAL administration. ATP levels decreased to 57.4 +/- 12.4% at 12 hours and to 65.4 +/- 7.7% at 24 hours after the administration compared with that in control rats. Pi levels increased remarkably to 632.1 +/- 76.4% at 3 hours and recovered to 127.5 +/- 22% at 24 hours. NAD+/NADH and UDP-sugar levels gradually increased to 253.5 +/- 33.4 and 456.3 +/- 60.9%, respectively, at 24 hours. In GAL treated livers, ATP levels fell rapidly and Pi levels rose correspondingly during ischemia, and they rapidly recovered by reperfusion. The intracellular pH decreased to 7.16 +/- 0.032 from 7.38 +/- 0.065 at 3 hours after GAL administration. However, significant changes in pH were not observed until 24 hours. In GAL treated livers, slight changes in pH were observed under ischemia. These results indicate that 31P-NMR is a useful method to evaluate the damage of acute liver failure, and to diagnose liver diseases involving the intrahepatic energy metabolism.
使用31P-NMR光谱法对D-半乳糖胺(GAL)诱导的急性肝衰竭中磷代谢产物和细胞内pH值的变化进行了无损连续评估。此外,还研究了缺血状态下这些参数的变化。将GAL(1.0g/kg)静脉注射给雄性Wistar大鼠。使用GX-270FT NMR光谱仪(JEOL)对灌注肝脏进行NMR测量。GAL给药后观察到31P-NMR光谱有典型变化。与对照大鼠相比,给药后12小时ATP水平降至57.4±12.4%,24小时降至65.4±7.7%。Pi水平在3小时时显著升高至632.1±76.4%,24小时时恢复至127.5±22%。NAD+/NADH和UDP-糖水平在24小时时分别逐渐升高至253.5±33.4%和456.3±60.9%。在GAL处理的肝脏中,缺血期间ATP水平迅速下降,Pi水平相应升高,再灌注后迅速恢复。GAL给药后3小时,细胞内pH值从7.38±0.065降至7.16±0.032。然而,直到24小时才观察到pH值的显著变化。在GAL处理的肝脏中,缺血状态下观察到pH值有轻微变化。这些结果表明,31P-NMR是评估急性肝衰竭损伤以及诊断涉及肝内能量代谢的肝脏疾病的一种有用方法。